Clinical TrialsShionogi Advances Tapinarof With Positive Infant Atopic Dermatitis Data Shionogi Advances Tapinarof With Positive Infant Atopic Dermatitis Data Read Post »
Clinical TrialsIpsen’s Dysport Holds Its Ground Against Botox in Head-to-Head Study Ipsen’s Dysport Holds Its Ground Against Botox in Head-to-Head Study Read Post »
Clinical TrialsANKTIVA Plus BCG Outperforms Approved NMIBC Therapies in AUA 2026 Analyses ANKTIVA Plus BCG Outperforms Approved NMIBC Therapies in AUA 2026 Analyses Read Post »
Clinical TrialsInnovent’s Dual-Target Antibody IBI3002 Shows Promise in Asthma Innovent’s Dual-Target Antibody IBI3002 Shows Promise in Asthma Read Post »
Clinical TrialsUCB Pushes BIMZELX Ahead of SKYRIZI in Psoriatic Arthritis Showdown UCB Pushes BIMZELX Ahead of SKYRIZI in Psoriatic Arthritis Showdown Read Post »
Clinical TrialsWave Expands Evidence for WVE-006 in Lung and Liver Manifestations of AATD Wave Expands Evidence for WVE-006 in Lung and Liver Manifestations of AATD Read Post »
Clinical TrialsAlterity Pushes ATH434 Toward Phase 3 With New MSA Disease-Modifying Signal... Alterity Pushes ATH434 Toward Phase 3 With New MSA Disease-Modifying Signal... Read Post »
Clinical TrialsBioMarin Sees Biomarker Win Fade Against Clinical Reality in ENERGY 3 Trial BioMarin Sees Biomarker Win Fade Against Clinical Reality in ENERGY 3 Trial Read Post »
Clinical TrialsSanofi Reports Positive Phase 2 Results for Efdoralprin Alfa in AATD Sanofi Reports Positive Phase 2 Results for Efdoralprin Alfa in AATD Read Post »
Clinical TrialsMerck’s Sac-TMT Shows Survival Benefit in Advanced Endometrial Cancer Merck’s Sac-TMT Shows Survival Benefit in Advanced Endometrial Cancer Read Post »
Clinical TrialsRalinepag Improved Outcomes in Phase III Pulmonary Hypertension Study Ralinepag Improved Outcomes in Phase III Pulmonary Hypertension Study Read Post »
Clinical TrialsNovartis Shows Improved PSA Responses With Pluvicto in Phase III mHSPC Tria... Novartis Shows Improved PSA Responses With Pluvicto in Phase III mHSPC Tria... Read Post »
Clinical TrialsFDA Clears United Therapeutics’ UHeart Trial in End-Stage Heart Failure FDA Clears United Therapeutics’ UHeart Trial in End-Stage Heart Failure Read Post »
Clinical TrialsRegeneron Continues Melanoma Development After Phase 3 Trial Miss Regeneron Continues Melanoma Development After Phase 3 Trial Miss Read Post »
Clinical TrialsXPro™ Shows Cognitive and Biomarker Benefits in Phase 2 Alzheimer’s Tri... XPro™ Shows Cognitive and Biomarker Benefits in Phase 2 Alzheimer’s Tri... Read Post »
Clinical TrialsPalvella Reports Phase 2 Data Supporting QTORIN in Rare Vascular Disorder Palvella Reports Phase 2 Data Supporting QTORIN in Rare Vascular Disorder Read Post »
Clinical TrialsAstraZeneca’s VOLGA Trial Shows Perioperative Imfinzi Plus Enfortumab Ved... AstraZeneca’s VOLGA Trial Shows Perioperative Imfinzi Plus Enfortumab Ved... Read Post »
Clinical TrialsBiogen’s Diranersen Falls Short on Primary Goal Yet Signals a Breakthroug... Biogen’s Diranersen Falls Short on Primary Goal Yet Signals a Breakthroug... Read Post »
Clinical TrialsEyePoint Confirms Favorable Safety Profile for DURAVYU in Phase 3 Wet AMD T... EyePoint Confirms Favorable Safety Profile for DURAVYU in Phase 3 Wet AMD T... Read Post »
Clinical TrialsREGENXBIO Delivers Positive Results for Duchenne Therapy RGX-202 REGENXBIO Delivers Positive Results for Duchenne Therapy RGX-202 Read Post »
Clinical TrialsShionogi Builds a New COVID-19 Defense Line With Positive Phase 3 Ensitrelv... Shionogi Builds a New COVID-19 Defense Line With Positive Phase 3 Ensitrelv... Read Post »
Clinical TrialsEncoded Presents Positive POLARIS Data for ETX101 in Dravet Syndrome Encoded Presents Positive POLARIS Data for ETX101 in Dravet Syndrome Read Post »
Clinical TrialsKura Oncology and Kyowa Kirin Report Updated Frontline Data from KOMET-007 ... Kura Oncology and Kyowa Kirin Report Updated Frontline Data from KOMET-007 ... Read Post »
Clinical TrialsNovo Nordisk Reports Up to 21.6% Weight Loss with Oral Wegovy in OASIS 4 An... Novo Nordisk Reports Up to 21.6% Weight Loss with Oral Wegovy in OASIS 4 An... Read Post »
Clinical TrialsAstellas’s IZERVAY Reduced Risk of Driving Eligibility Loss in Geogra... Astellas’s IZERVAY Reduced Risk of Driving Eligibility Loss in Geogra... Read Post »
Clinical TrialsLilly Reports Long-Term Weight Maintenance Data for Foundayo and Zepbound a... Lilly Reports Long-Term Weight Maintenance Data for Foundayo and Zepbound a... Read Post »
Clinical TrialsAlnylam Reports Consistent HELIOS-B Benefits of Vutrisiran in ATTR-CM Alnylam Reports Consistent HELIOS-B Benefits of Vutrisiran in ATTR-CM Read Post »
Clinical TrialsNovo Nordisk Presents New Wegovy Menopause Data at ECO 2026 Novo Nordisk Presents New Wegovy Menopause Data at ECO 2026 Read Post »
Clinical TrialsBridgeBio Files FDA NDA for Encaleret in Rare Calcium Disorder BridgeBio Files FDA NDA for Encaleret in Rare Calcium Disorder Read Post »
Clinical TrialsAstraZeneca Pushes Eneboparatide Forefront in Hypoparathyroidism with CALYP... AstraZeneca Pushes Eneboparatide Forefront in Hypoparathyroidism with CALYP... Read Post »
Clinical TrialsNovo Nordisk Shows 27.7% Weight Loss With Higher-Dose Wegovy in STEP UP Tri... Novo Nordisk Shows 27.7% Weight Loss With Higher-Dose Wegovy in STEP UP Tri... Read Post »
Clinical TrialsCytokinetics Unveils New MYQORZO Clinical and Real-World Data at ESC 2026 Cytokinetics Unveils New MYQORZO Clinical and Real-World Data at ESC 2026 Read Post »
Clinical TrialsBridgeBio Presents New ATTRibute-CM Data Supporting Acoramidis at Heart Fai... BridgeBio Presents New ATTRibute-CM Data Supporting Acoramidis at Heart Fai... Read Post »
Clinical TrialsViiV Advances Paediatric HIV Care with Dovato Submissions to EMA and FDA ViiV Advances Paediatric HIV Care with Dovato Submissions to EMA and FDA Read Post »
Clinical TrialsAtsena Presents Encouraging Long-Term Data in XLRS and LCA1 Atsena Presents Encouraging Long-Term Data in XLRS and LCA1 Read Post »
Clinical TrialsFDA Clears NRX-101 Study in Treatment-Resistant Depression and Suicidality FDA Clears NRX-101 Study in Treatment-Resistant Depression and Suicidality Read Post »
Clinical TrialsEntrada Strengthens Its Duchenne Pipeline With Positive ENTR-601-44 Study R... Entrada Strengthens Its Duchenne Pipeline With Positive ENTR-601-44 Study R... Read Post »
Clinical TrialsIncyte Shows Durable 24-Week Response With Opzelura in Moderate AD Incyte Shows Durable 24-Week Response With Opzelura in Moderate AD Read Post »
Clinical TrialsMirum Plans NDA Submission After Positive Volixibat PSC Results Mirum Plans NDA Submission After Positive Volixibat PSC Results Read Post »
Clinical TrialsJohnson & Johnson Breaks a Two-Decade Silence in Perianal Crohn’s Dis... Johnson & Johnson Breaks a Two-Decade Silence in Perianal Crohn’s Dis... Read Post »
Clinical TrialsAbbVie Sharpens Its IBD Edge With Real-World SKYRIZI and RINVOQ Results AbbVie Sharpens Its IBD Edge With Real-World SKYRIZI and RINVOQ Results Read Post »
Clinical TrialsCytokinetics Shifts the Hypertrophic Landscape: Aficamten Scores in ACACIA ... Cytokinetics Shifts the Hypertrophic Landscape: Aficamten Scores in ACACIA ... Read Post »
Clinical TrialsViridian Therapeutics Tightens Grip on TED Pipeline With REVEAL-2 Milestone Viridian Therapeutics Tightens Grip on TED Pipeline With REVEAL-2 Milestone Read Post »
Clinical TrialsOncolytics Biotech Reports Strong Early Data for Pelareorep in mCRC Oncolytics Biotech Reports Strong Early Data for Pelareorep in mCRC Read Post »
Clinical TrialsLilly Drives Long-Term Stability in UC with Omvoh LUCENT-3 Findings Lilly Drives Long-Term Stability in UC with Omvoh LUCENT-3 Findings Read Post »
Clinical TrialsJohnson & Johnson Doubles Down on IBD Inflammation with Dual-Target The... Johnson & Johnson Doubles Down on IBD Inflammation with Dual-Target The... Read Post »
Clinical TrialsRegeneron and Sanofi Confirm Dupixent Benefits in Eosinophilic Esophagitis Regeneron and Sanofi Confirm Dupixent Benefits in Eosinophilic Esophagitis Read Post »
Clinical TrialsNetwork Analysis Shows CAPLYTA Favored in Adjunctive MDD Treatment Network Analysis Shows CAPLYTA Favored in Adjunctive MDD Treatment Read Post »
Clinical TrialsTakeda’s TAK-881 delivers comparable results to HYQVIA in PID Takeda’s TAK-881 delivers comparable results to HYQVIA in PID Read Post »
Clinical TrialsNanoViricides, Inc. Secures FDA Orphan Designation for NV-387 Measles Thera... NanoViricides, Inc. Secures FDA Orphan Designation for NV-387 Measles Thera... Read Post »
